G
G. Chad Hughes
Researcher at Duke University
Publications - 244
Citations - 11712
G. Chad Hughes is an academic researcher from Duke University. The author has contributed to research in topics: Aortic dissection & Aortic valve replacement. The author has an hindex of 47, co-authored 224 publications receiving 9664 citations. Previous affiliations of G. Chad Hughes include Durham University & University of Michigan.
Papers
More filters
Journal ArticleDOI
Transcatheter Aortic Valve Replacement with a Self-Expanding Prosthesis
David H. Adams,Jeffrey J. Popma,Michael J. Reardon,Steven J. Yakubov,Joseph S. Coselli,G. Michael Deeb,Thomas G. Gleason,Maurice Buchbinder,James B. Hermiller,Neal S. Kleiman,Stan Chetcuti,John Heiser,William Merhi,George L. Zorn,Peter Tadros,Newell Robinson,George Petrossian,G. Chad Hughes,J. Kevin Harrison,John V. Conte,Brijeshwar Maini,Mubashir Mumtaz,Sharla Chenoweth,Jae K. Oh +23 more
TL;DR: In patients with severe aortic stenosis who are at increased surgical risk, TAVR with a self-expanding transcatheter aorti-valve bioprosthesis was associated with a significantly higher rate of survival at 1 year than surgical aorticsvalve replacement.
Journal ArticleDOI
Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery.
Jeffrey J. Popma,David H. Adams,Michael J. Reardon,Steven J. Yakubov,Neal S. Kleiman,David Heimansohn,James B. Hermiller,G. Chad Hughes,J. Kevin Harrison,Joseph S. Coselli,Jose G Diez,Ali Kafi,Theodore Schreiber,Thomas G. Gleason,John V. Conte,Maurice Buchbinder,G. Michael Deeb,Blase A. Carabello,Patrick W. Serruys,Sharla Chenoweth,Jae K. Oh +20 more
TL;DR: TAVR with a self-expanding bioprosthesis was safe and effective in patients with symptomatic severe aortic stenosis at prohibitive risk for surgical valve replacement.
Journal ArticleDOI
2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve Replacement
Michael J. Reardon,David H. Adams,Neal S. Kleiman,Steven J. Yakubov,Joseph S. Coselli,G. Michael Deeb,Thomas G. Gleason,Joon S. Lee,James B. Hermiller,Stan Chetcuti,John Heiser,William Merhi,George L. Zorn,Peter Tadros,Newell Robinson,George Petrossian,G. Chad Hughes,J. Kevin Harrison,Brijeshwar Maini,Mubashir Mumtaz,John V. Conte,Jon R. Resar,Vicken Aharonian,Thomas A. Pfeffer,Jae K. Oh,Hongyan Qiao,Jeffrey J. Popma +26 more
TL;DR: In patients with severe aortic stenosis who are at increased surgical risk, the higher rate of survival with a self-expanding TAVR compared with surgery was sustained at 2 years.
Journal ArticleDOI
Society for Vascular Surgery (SVS) and Society of Thoracic Surgeons (STS) reporting standards for type B aortic dissections
Joseph V. Lombardi,G. Chad Hughes,Jehangir J. Appoo,Joseph E. Bavaria,Adam W. Beck,Richard P. Cambria,Kristofer M. Charlton-Ouw,Mohammad H. Eslami,Karen M. Kim,Bradley G. Leshnower,Thomas S. Maldonado,T. Brett Reece,Grace J. Wang +12 more
TL;DR: This Society for Vascular Surgery/Society of Thoracic Surgeons (SVS/STS) document illustrates and defines the overall nomenclature associated with type B aortic dissection and describes a new classification system for practical use and reporting that includes the aorti arch.
Journal ArticleDOI
3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement
G. Michael Deeb,Michael J. Reardon,Stan Chetcuti,Himanshu J. Patel,P. Michael Grossman,Steven J. Yakubov,Neal S. Kleiman,Joseph S. Coselli,Thomas G. Gleason,Joon S. Lee,James B. Hermiller,John Heiser,William Merhi,George L. Zorn,Peter Tadros,Newell Robinson,George Petrossian,G. Chad Hughes,J. Kevin Harrison,Brijeshwar Maini,Mubashir Mumtaz,John V. Conte,Jon R. Resar,Vicken Aharonian,Thomas A. Pfeffer,Jae K. Oh,Hongyan Qiao,David H. Adams,Jeffrey J. Popma,CoreValve U.S. Pivotal High Risk Trial Clinical Investigators +29 more
TL;DR: Patients with severe aortic stenosis at increased risk for surgery had improved 3-year clinical outcomes after TAVR compared with surgery, and aorti valve hemodynamics were more favorable in TAVr patients without differences in structural valve deterioration.